Thank you, Mr. Chair.
Our conversation shows that the cornerstone of Bill C‑277 is research. Promoting research is a major part of this bill, and I think that it's vital. In my opinion, this should have been the central pillar of the bill.
We were talking earlier about access to treatment. It's great to have access to treatment. However, if the treatment is outdated or not entirely suitable, then we fall short of our objective.
Ms. Beauchamp, you said that funding should be increased. You spoke of a specific and direct investment in the brain injury issue. You also talked about collaborative Canada‑wide initiatives aimed at sharing expertise and developing a coordinated strategy.
However, you also referred to the recommendations made in the Bouchard report, meaning the report of the advisory panel on the federal research support system.
Could you elaborate on this topic?